Bioinformatics and In Vivo Experiments Identify Hmgcs2 as a Key Gene Linking Fatty Acid Metabolism and Lactylation in Acute Kidney Injury Associated with Sepsis

Abstract Background Sepsis-associated acute kidney injury (S-AKI) is a severe critical care complication with high morbidity and mortality, involving inflammatory dysregulation, metabolic reprogramming, and immune dysfunction. However, the molecular link between fatty acid metabolism disorders and lactylation in S-AKI remains unclear, and systematic screening with functional validation is lacking. Methods Based on mouse kidney transcriptome datasets, we performed DEGs analysis, GSEA, GO/KEGG enrichment, and LASSO regression to screen key candidates. Intersection analyses with fatty acid metabolism and lactylation-related gene sets were conducted to identify core targets. Diagnostic value was evaluated by ROC curves, immune infiltration by CIBERSORT, and in vivo validation in a CLP-induced S-AKI mouse model. Results A total of 359 DEGs were identified, with GSEA revealing significant enrichment of inflammation and metabolism pathways. LASSO narrowed candidates to 16 feature genes. Four-set Venn intersection identified Hmgcs2 as the only core target intersecting both fatty acid metabolism and lactylation-related gene sets. ROC analysis confirmed good diagnostic efficacy (AUC > 0.7). Immune infiltration showed increased M0 macrophages and neutrophils in S-AKI, significantly correlated with Hmgcs2 expression. In vivo experiments confirmed significant upregulation of Hmgcs2 mRNA and protein in renal tissues after CLP. Conclusion This study, integrating bioinformatics, machine learning, and in vivo experiments, incorporates fatty acid metabolism and lactylation into a unified screening framework and identifies Hmgcs2 as a key network node bridging these two dimensions. As the rate-limiting enzyme of ketogenesis, Hmgcs2 may regulate renal energy homeostasis through FAO and potentially influence lactylation-related epigenetic networks by reshaping the metabolic microenvironment, exerting renoprotective effects in S-AKI. Hmgcs2 shows promise as a diagnostic biomarker and therapeutic target for S-AKI.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11306189/v1
Primary Topic
Acute Kidney Injury Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Bioinformatics and In Vivo Experiments Identify Hmgcs2 as a Key Gene Linking Fatty Acid Metabolism and Lactylation in Acute Kidney Injury Associated with Sepsis

Xuan Shang, Na Xia, Yawen Wu, Hongmei Zhang et al.
Research Square
Acute Kidney Injury Research
preprint

Bioinformatics and In Vivo Experiments Identify Hmgcs2 as a Key Gene Linking Fatty Acid Metabolism and Lactylation in Acute Kidney Injury Associated with Sepsis

Xuan Shang, Na Xia, Yawen Wu, Hongmei Zhang, Jianying Bai, Jinzhi Song, Gehui Xiao, Xueqin Li
preprint en

Abstract

Abstract Background Sepsis-associated acute kidney injury (S-AKI) is a severe critical care complication with high morbidity and mortality, involving inflammatory dysregulation, metabolic reprogramming, and immune dysfunction. However, the molecular link between fatty acid metabolism disorders and lactylation in S-AKI remains unclear, and systematic screening with functional validation is lacking. Methods Based on mouse kidney transcriptome datasets, we performed DEGs analysis, GSEA, GO/KEGG enrichment, and LASSO regression to screen key candidates. Intersection analyses with fatty acid metabolism and lactylation-related gene sets were conducted to identify core targets. Diagnostic value was evaluated by ROC curves, immune infiltration by CIBERSORT, and in vivo validation in a CLP-induced S-AKI mouse model. Results A total of 359 DEGs were identified, with GSEA revealing significant enrichment of inflammation and metabolism pathways. LASSO narrowed candidates to 16 feature genes. Four-set Venn intersection identified Hmgcs2 as the only core target intersecting both fatty acid metabolism and lactylation-related gene sets. ROC analysis confirmed good diagnostic efficacy (AUC > 0.7). Immune infiltration showed increased M0 macrophages and neutrophils in S-AKI, significantly correlated with Hmgcs2 expression. In vivo experiments confirmed significant upregulation of Hmgcs2 mRNA and protein in renal tissues after CLP. Conclusion This study, integrating bioinformatics, machine learning, and in vivo experiments, incorporates fatty acid metabolism and lactylation into a unified screening framework and identifies Hmgcs2 as a key network node bridging these two dimensions. As the rate-limiting enzyme of ketogenesis, Hmgcs2 may regulate renal energy homeostasis through FAO and potentially influence lactylation-related epigenetic networks by reshaping the metabolic microenvironment, exerting renoprotective effects in S-AKI. Hmgcs2 shows promise as a diagnostic biomarker and therapeutic target for S-AKI.

Research Square
Shanxi Medical University (CN)
Good health and well-being
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon